COMP <GO>
HUM vs ELV // EV/EBITDA & P/E VALUATION
Humana Inc. (NYSE) VS. Elevance Health Inc. (NYSE) • 15-METRIC TALLY: HUM 2
— ELV 10
▲ EV/EBITDA & P/E VALUATION LEADER: ELV
LAST: $414.50 (-0.73%) • MKT CAP: $50.14B
valuation
18.4x
LAST: $420.07 (-0.46%) • MKT CAP: $91.18B
valuation
13.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HUM VS. ELV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HUM | ELV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 89.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.30% | 8.70% | -0.40 | ELV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.4x | 13.8x | +4.60 | ELV | /valuation <GO> |
| Free Cash Flow Yield | 0.75% | 3.48% | -2.73 | ELV | /fcf-yield <GO> |
| Operating Margin | 2.10% | 3.60% | -1.50 | ELV | /operating-margins <GO> |
| Net Profit Margin | 0.90% | 2.80% | -1.90 | ELV | /net-margins <GO> |
| Revenue Growth (YoY) | 10.10% | 12.50% | -2.40 | ELV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.86% | 1.68% | -0.82 | ELV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.03 | 3.17 | +1.86 | HUM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.9 | 52.0 | +1.90 | HUM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 1.07 | -0.19 | ELV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 39.2x | 13.5x | +25.70 | ELV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $50.14B | $91.18B | -$41.04B | ELV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HUM REV | ELV REV | HUM GROSS % | ELV GROSS % | HUM FCF | ELV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $129.66B | $199.13B | — | 89.4% | $375.0M | $3.17B |
| FY 2024 | $117.76B | $177.01B | — | 88.8% | $2.39B | $4.55B |
| FY 2023 | $106.37B | $171.34B | — | — | -$805.8M | $350.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HUM // BETA 0.88
ELV // BETA 1.07